Levosimendan is being evaluated as a potential alternative to milrinone for adults with pulmonary hypertension, but the abstract provides no specific efficacy results.
Tasa de eventos absoluta: 0% vs 0%
Levosimendan, is a potential alternative to Milrinone for patients with pulmonary hypertension. The aim of this meta-analysis is to evaluate the efficacy of Levosimendan versus Milrinone in adults with pulmonary hypertension.
Rizwan et al. (Wed,) reported a other. Levosimendan is being evaluated as a potential alternative to milrinone for adults with pulmonary hypertension, but the abstract provides no specific efficacy results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: